Berlin, Germany | October 21st - 24th, 2012

 

Company Profile Novartis

Novartis

Novartis is a leading worldwide research-based healthcare company. The declared mission of Novartis is to research, develop and successfully market innovative products and thus heal diseases, alleviate suffering and enhance the long-term quality of life. In doing so, we accompany people from the prevention to the treatment of serious diseases. With patent-protected products, we are committed to combating cancer, heart, cardiovascular and nerve diseases, allergic and respiratory conditions as well as to the treatment of eye diseases, for transplants or bone disorders.

More than 30 million patients benefited from Novartis products last year. With sales of about 3.04 billion € and a market share of 12.2 percent, Novartis is the largest company in the German health sector. The company employs about 8,100 people in Germany. Worldwide, some 102.000 employees are at work in more than 140 countries.

In 2009, Novartis Pharma conducted 150 clinical trials from which more than 16,000 patients benefited – Novartis is therefore known as the German Champion of clinical development.

You will find more information at: www.novartis.de.

Search

Important Dates

May 31st , 2012:
Start of Registration

NEWSLETTER

To get the latest updates, please sign up here for our newsletter.

Submit Abstract

The Abstract Submission system is now open!
Click here to submit your abstract.

VIDEO WHS

Testimonials 2011

Please click here to find the Testimonials 2011.

Key Messages

Find the World Health Summit Key Messages here.

Social Media

 
 
© 2010 World Health Summit HOME|CONTACT|SITEMAP|LEGAL NOTICE
Twitter  Facebook  Youtube